These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30368075)

  • 1. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
    Lin HS; Lin CH
    J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
    Lin CH; Park C; McIntyre RS
    J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.
    Lin CH; Chen MC; Yang WC; Lane HY
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):225-233. PubMed ID: 26718791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
    Lin CH; Huang CJ; Chen CC
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
    Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
    Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melancholic features in inpatients with major depressive disorder associate with differential clinical characteristics and treatment outcomes.
    Lin CH; Huang CJ; Liu SK
    Psychiatry Res; 2016 Apr; 238():368-373. PubMed ID: 26899817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.
    Lin CH; Chen CC; Wong J; McIntyre RS
    J Affect Disord; 2014 Jun; 161():123-6. PubMed ID: 24751319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
    Lin CH; Chen CC; Wang FC; Lane HY
    Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Hamilton rating scale for depression subset scales and full versions for electroconvulsive therapy.
    Fenton C; McLoughlin DM
    PLoS One; 2021; 16(11):e0259861. PubMed ID: 34752484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.
    Farabaugh AH; Bitran S; Witte J; Alpert J; Chuzi S; Clain AJ; Baer L; Fava M; McGrath PJ; Dording C; Mischoulon D; Papakostas GI
    Int Clin Psychopharmacol; 2010 Jul; 25(4):214-7. PubMed ID: 20400905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive Therapy Versus Fluoxetine in Suicidal Resolution for Patients With Major Depressive Disorder.
    Lin CH; Chen CC; Huang CJ
    J ECT; 2020 Dec; 36(4):234-241. PubMed ID: 32205736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder.
    Lin CH; Chou LS; Chen MC; Chen CC
    J Affect Disord; 2015 Aug; 182():115-20. PubMed ID: 25985380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.
    Yang WC; Lin CH; Wang FC; Lu MJ
    BMC Psychiatry; 2017 Aug; 17(1):309. PubMed ID: 28841824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
    Lin CH; Lin HS; Lin SC; Kuo CC; Wang FC; Huang YH
    Acta Psychiatr Scand; 2018 Feb; 137(2):98-108. PubMed ID: 29280500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do baseline WAIS-III subtests predict treatment outcomes for depressed inpatients receiving fluoxetine?
    Lin CH; Chou LS; Tang SH; Huang CJ
    Psychiatry Res; 2019 Jan; 271():279-285. PubMed ID: 30513459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early improvement as a predictor of final remission in major depressive disorder: New insights in electroconvulsive therapy.
    Martínez-Amorós E; Goldberg X; Gálvez V; de Arriba-Arnau A; Soria V; Menchón JM; Palao DJ; Urretavizcaya M; Cardoner N
    J Affect Disord; 2018 Aug; 235():169-175. PubMed ID: 29656263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.